series-c-plus
Stage
2011
Founded
2
Investors
About
Biocartis is an innovative molecular diagnostics company that revolutionizes molecular testing with its proprietary Idylla™ platform, offering next-generation diagnostic solutions focused on oncology and infectious diseases to improve clinical practice and patient outcomes.
Explore Biocartis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.